Guard Therapeutics Announces Top-Line Results from Phase 2b POINTER Study Guard Therapeutics (publ) announced top-line results from the Phase 2b POINTER study, evaluating RMC-035 as a kidn…
Bulls Shake Off Illness to Claim ALM Win Over Reds Macarthur FC have defeated Adelaide for their first victory of the A-League Men season,…
Nokia, Ericsson and Fraunhofer Partnership for NextGen Video Compression Nokia, Ericsson, and Germany's Fraunhofer Heinrich Hertz Institut…
AGRITECHNICA: Fraunhofer Presents Innovations for the Agriculture of Tomorrow Climate change, resource scarcity, and growing sustainabilit…
Food System Innovations Receives $2M Grant Food System Innovations (FSI), a philanthropic impact platform, has received $2 million from th…
SAHPRA Approves Groundbreaking HIV Prevention Injection The South African Health Products Regulatory Authority (SAHPRA) has approved a new…
Amphista Therapeutics Achieves Breakthrough in Cancer Target Degradation Amphista Therapeutics, a leader in next-generation targeted prote…
Teachers Licensing Initiative to Uphold Education Standards The Botswana Teaching Professionals Councils (BOTEPCO) has launched a teacher …
Compulsory Voting: A Remedy or Ruse for Democracy? The debate over compulsory voting revolves around a trade-off between participation and…
Nanoform Partners with Revio Therapeutics Nanoform Finland Plc, a medicine performance-enhancing company, announced a partnership with Rev…
Hemab Secures $157M to Address 'Underserved' Blood Diseases Hemab, a startup with medicines in testing and development, aims to build the …